By Elizabeth Osayande
The World Health Organisation, WHO Representative and Head of Mission in Nigeria, Dr Pavel Ursu, has challenged Nigerian universities and faculties of pharmacy to make academic research more responsive to the country’s pharmaceutical and healthcare needs, calling for stronger partnerships between higher education institutions and the pharmaceutical industry.
Ursu, represented by the WHO representative in Lagos State, Dr Akinola Ayoola Fatiregun, made the call while delivering a keynote address at the 2026 Fellowship Investiture of the Nigeria Academy of Pharmacy, NAPHARM.
The ceremony, themed “Pharmacy for National Health Security: Advancing Innovation, Medicine Sovereignty and Sustainable Healthcare,” brought together stakeholders in pharmacy, academia, pharmaceutical manufacturing and healthcare to discuss the role of the profession in strengthening Nigeria’s health security.
Addressing the relationship between academic research and industrial production, Ursu said universities possessed significant research expertise, but stronger connections with pharmaceutical manufacturers were needed to translate discoveries into commercially viable products.
“Your faculties hold much of that talent. Your industry holds the factories. What is often missing is the bridge – the translational funding, the shared pilot plant, the regulatory science advice that turns a thesis into a dossier,” he said.
He identified process chemistry, heat-stable formulations, phytomedicine research and digital track-and-trace systems as areas where Nigerian researchers could contribute to pharmaceutical innovation and the development of local manufacturing capacity.
Ursu urged academics to direct their research towards practical challenges affecting Nigeria’s pharmaceutical sector, including reducing the cost of producing active pharmaceutical ingredients and developing medicines capable of remaining stable under local climatic conditions.
He also encouraged researchers to generate evidence demonstrating how pharmacy services could improve health outcomes while reducing healthcare costs.
“Make your research answer Nigeria’s questions – how to make this molecule cheaper here, how to keep this product stable in our climate, how to prove that this pharmacy service saves lives and money,” he said.
He further challenged academics to ensure that their research reached policymakers and contributed to policy decisions rather than remaining within academic publications.
“Publish it where policymakers will read it, and follow up with advocacy,” he added.
The WHO representative identified the weak connection between academic research and industrial production as a major challenge to pharmaceutical innovation, noting that discoveries made in universities required additional support to become products suitable for commercial manufacturing.
He proposed translational funding, shared pilot plants and regulatory science support as practical mechanisms for bridging the gap between research institutions and the pharmaceutical industry.
Such collaboration, he noted, would help researchers move beyond producing academic findings to developing solutions that respond directly to the country’s medicine production and healthcare requirements.
The President and Chairman of the Academy’s Governing Council, Prof. Lere Baale, also advocated stronger collaboration among government, universities, research institutions, pharmaceutical manufacturers and regulatory agencies to strengthen domestic pharmaceutical production.
Baale emphasised the need for Nigerian universities to become engines of discovery and enterprise, contributing research and innovation that could support the country’s pharmaceutical industry.
Addressing the newly inducted Fellows, he challenged each of them to identify at least one significant contribution they would make to the Academy and Nigeria’s pharmaceutical development within their first 12 months of Fellowship.
His charge placed emphasis on the responsibility of professional recognition, urging the new Fellows to translate their experience and expertise into measurable contributions to the profession and the country’s healthcare system.
Speaking with journalists after the ceremony, Baale also urged the new Fellows to remain impactful and contribute to the Academy’s ongoing professional development and public education activities.
He said NAPHARM had been organising mentoring programmes and awareness initiatives, particularly to educate younger people and members of the public about identifying fake medicines.
“We are doing a lot of mentoring programmes. We are also doing a lot in the aspect of creating awareness. We expect that various pharmacists in community practice will be educating the general public,” he said.
The 2026 investiture also featured the presentation of honorary fellowships and a lifetime achievement award to individuals recognised for their contributions to education and pharmaceutical development.
The Academy conferred honorary fellow awards on Alhaji Auwalu Abdullahi Rano, founder and Chief Executive Officer of A. A. Rano Group of Companies, and Dr Obiora Anthony Chukwuka, Executive Chairman of Greenlife Pharmaceuticals Limited.
A lifetime achievement award was presented to Pharmacist Mrs (Dr) Stella Okoli, Chief Executive Officer and founder of Emzor Pharmaceutical Industries Limited.
The Academy recognised Okoli for her contributions to the pharmaceutical industry and her example of resilience, innovation, and service to Nigeria and Africa.
For the 2026 investiture, eleven professionals were inducted as Fellows of the academy during the ceremony.
They are Dr Shakirat Adeshiyan Adeosun, Dr Solomon Aigbavboa, Pharm Ignatius Kenechukwu Anukwu, Dr Josephine Ihanene Ehimen, Pharm Bankole Aminu Ezebuilo and Pharm Rasheed Oladele Faworaja.
Others are Dr Ukamaka Gladys Okafor, Prof Henry Akpobor Okeri, Prof Ogbonna Okorie, Prof Ibrahim Adekunle Oreagba and Dr Titilayo Abidemi Onedo.
The investiture provided an opportunity to recognise professional contributions while renewing calls for pharmacists, researchers, universities, manufacturers and government institutions to work together towards strengthening Nigeria’s pharmaceutical capacity.

No comments yet. Start the conversation.